Previous 10 | Next 10 |
2023-08-01 04:44:27 ET Summary Smith & Nephew plc is a long-standing company in the medical device sector, focusing on developing and manufacturing internationally. The company has recently received FDA clearance for its AETOS Shoulder System, aiming to gain market share in th...
2023-07-14 04:30:00 ET Summary Fiduciary Management, Inc. is an independent money management firm. FMI’s equity investing strategies apply a value discipline, with a focused approach firmly rooted in fundamental research. FMI’s Small Cap and International Strategies ...
2023-06-29 05:08:31 ET Morgan Stanley is making some moves in its model for income-focused investors. It is adding two new positions with Rio Tinto ( NYSE: RIO ) and Smith & Nephew ( SNN ), swapping out Amgen ( AMGN ) and the iShares MSCI Hong Kong ETF ( EWH ). ...
VANCOUVER, British Columbia, June 12, 2023 (GLOBE NEWSWIRE) -- Sunniva Inc. (“Sunniva”, the “Company”) (CSE:SNN) (OTC Pink Sheets: SNNVF) provides the following corporate update. Sunniva and its subsidiaries, including CP Logistics, LLC (“CPL”), hav...
2023-06-12 11:17:28 ET Medical device maker Smith+Nephew ( NYSE: SNN ) has received market clearance from the US Food and Drug Administration for its AETOS shoulder implant system. The system is used to help restore range-of-motion and minimize arthritic shoulder pain. More ...
Smith+Nephew announces 510(k) clearance of its AETOS™ Shoulder System for anatomic and reverse shoulder replacement PR Newswire LONDON , June 12, 2023 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces i...
Smith+Nephew helps personalize robotically-enabled surgery with AI-powered planning software and data visualization platform PR Newswire LONDON , May 16, 2023 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today intro...
2023-05-14 01:05:59 ET Summary Smith & Nephew has caught a 21% bid in the past 6 months despite no major fundamental changes. Long-term data analysis reveals the company's difficulty in turning capital investments into additional market valuation. Shares look to be fairly ...
Smith+Nephew receives Innovative Technology contract from Vizient for PICO™ Single Use Negative Pressure Wound Therapy Systems PR Newswire Contract awarded for products that bring improvement to healthcare industry LONDON , May 2, 2023 /PRNewswire/...
Smith+Nephew introduces first of its kind handheld digital tensioning device for robotically-enabled total knee arthroplasty PR Newswire LONDON , April 24, 2023 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today int...
News, Short Squeeze, Breakout and More Instantly...
Smith & Nephew SNATS Inc. Company Name:
SNN Stock Symbol:
NYSE Market:
Smith & Nephew SNATS Inc. Website:
2024-07-24 05:15:02 ET Deutsche Bank analyst issues BUY recommendation for SNN on July 24, 2024 04:31AM ET. SNN was trading at $28.52 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 2 - Buy, 1 - Hold reco...
Engineered for precision, confidence and efficiency in surgery - and compatible with the CORI ◊ Surgical System Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has received 510(k) clearance for its new CATALYSTEM Primary Hip System fro...
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company announces its Orthopaedics for All initiative – a global advisory board established to amplify diversity by building equity, breaking biases, and inspiring inclusion for individuals wishing to pursue a career in ort...